Medigene

Medigene is a listed biopharmaceutical company headquartered in Munich that develops and commercialises novel drugs against cancer and autoimmune diseases

Medigene acquired Trianta Immunotherapies, a transformational deal that boosts Medigene’s pipeline through three innovative immunotherapy platforms with clinical development programs to treat cancer
Kempen & Co acted as sole financial adviser to Medigene